Status:
UNKNOWN
Linezolid in Healthy Volunteers
Lead Sponsor:
Prince of Songkla University
Conditions:
Healthy
Eligibility:
All Genders
20-40 years
Phase:
PHASE1
Brief Summary
Linezolid is the first synthetic antibiotic of oxazolidinone group that can inhibit bacterial protein synthesis. Previous studies have found that linezolid was an effective treatment for multidrug-res...
Eligibility Criteria
Inclusion
- Age 20 - 40
- BMI 19 - 24 kg/m2
- normal CLcr
- normal liver function
Exclusion
- Subject who pregnant
- Subject who have documented hypersensitivity to linezolid
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03841721
Start Date
May 1 2018
End Date
December 31 2019
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University
Hat Yai, Changwat Songkhla, Thailand, 90110